orudis hart forðahylki 100 mg
sanofi-aventis norge as - ketoprofenum inn - hart forðahylki - 100 mg
pentavac stungulyfsstofn og dreifa, dreifa
sanofi pasteur* - filamentous haemagglutinin; poliovirus inactivated type 2; poliovirus inactivated type 3; diphtheria toxoid; tetanus toxoid; poliovirus inactivated type 1; pertussis toxoid; haemophilus influenzae type b - stungulyfsstofn og dreifa, dreifa
solian tafla 200 mg
sanofi-aventis norge as - amisulpridum inn - tafla - 200 mg
solian tafla 50 mg
sanofi-aventis norge as - amisulpridum inn - tafla - 50 mg
repevax stungulyf, dreifa áfyllt sprauta
sanofi pasteur* - tetanus toxoid; diphtheria toxoid; pertussis toxoid; filamentous haemagglutinin; pertussis fimbrial agglutinogens (fim) 2 and 3; pertactin; poliovirus (inactivated) type 1 (mahoney strain); poliovirus (inactivated) type 2 (mef-1 strain); poliovirus (inactivated) type 3 (saukett strain) - stungulyf, dreifa - áfyllt sprauta
stamaril stungulyfsstofn og leysir, dreifa
sanofi pasteur* - gulusóttarveira 17d-204 stofn (lifandi, veikluð) - stungulyfsstofn og leysir, dreifa
cordarone tafla 200 mg
sanofi-aventis norge as - amiodaronum hýdróklóríð - tafla - 200 mg
cordarone tafla 100 mg
sanofi-aventis norge as - amiodaronum hýdróklóríð - tafla - 100 mg
klexane stungulyf, lausn áfyllt sprauta 100 mg/ml
sanofi-aventis norge as - enoxaparinum natricum inn - stungulyf, lausn - áfyllt sprauta 100 mg/ml
klexane stungulyf, lausn í hettuglösum 100 mg/ml
sanofi-aventis norge as - enoxaparinum natricum inn - stungulyf, lausn - í hettuglösum 100 mg/ml